Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) price on Friday, May 02, rose 10.86% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $20.00.
A look at the stock’s price movement, the close in the last trading session was $18.04, moving within a range at $18.11 and $20.24. The beta value (5-Year monthly) was 1.514. Turning to its 52-week performance, $672.00 and $6.76 were the 52-week high and 52-week low respectively. Overall, TNXP moved 15.01% over the past month.
Tonix Pharmaceuticals Holding Corp’s market cap currently stands at around $137.56 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-17.
Analysts have a consensus estimate of 2.55M for the company’s revenue for the quarter, with a low and high estimate of 2.5M and 2.6M respectively. The average forecast suggests up to a 2.74% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 11.1M, representing a 9.97% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TNXP is a Hold. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 4 recommend TNXP as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TNXP’s current price about 16.79% and 22.48% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 58.12, while 7-day volatility ratio is 8.37% and 11.38% in the 30-day chart. Further, Tonix Pharmaceuticals Holding Corp (TNXP) has a beta value of 1.64, and an average true range (ATR) of 2.26.
If we refocus on Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP), historical trading data shows that trading volumes averaged 0.64 over the past 10 days and 1.56 million over the past 3 months. The company’s latest data on shares outstanding shows there are 4.39 million shares.
The 0.00% of Tonix Pharmaceuticals Holding Corp’s shares are in the hands of company insiders while institutional holders own 2.49% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.12 million on 2025-04-15, giving us a short ratio of 0.68. The data shows that as of 2025-04-15 short interest in Tonix Pharmaceuticals Holding Corp (TNXP) stood at 1630.9999 of shares outstanding, with shares short rising to 0.88 million registered in 2025-03-14. Current price change has pushed the stock -39.36% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TNXP stock continues to rise going into the next quarter.
